NDLI: Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer

Content Provider	PubMed Central
Author	Chu, Zhengtao Shadi, Abu-baker Palascak, Mary B. Ahmad, Syed A. Franco, Robert S. Qi, Xiaoyang
Editor	Ahmad, Aamir
Copyright Year	2013
Abstract	Only a small number of promising drugs target pancreatic cancer, which is the fourth leading cause of cancer deaths with a 5-year survival of less than 5%. Our goal is to develop a new biotherapeutic agent in which a lysosomal protein (saposin C, SapC) and a phospholipid (dioleoylphosphatidylserine, DOPS) are assembled into nanovesicles (SapC-DOPS) for treating pancreatic cancer. A distinguishing feature of SapC-DOPS nanovesicles is their high affinity for phosphatidylserine (PS) rich microdomains, which are abnormally exposed on the membrane surface of human pancreatic tumor cells. To evaluate the role of external cell PS, in vitro assays were used to correlate PS exposure and the cytotoxic effect of SapC-DOPS in human tumor and nontumorigenic pancreatic cells. Next, pancreatic tumor xenografts (orthotopic and subcutaneous models) were used for tumor targeting and therapeutic efficacy studies with systemic SapC-DOPS treatment. We observed that the nanovesicles selectively killed human pancreatic cancer cells in vitro by inducing apoptotic death, whereas untransformed cells remained unaffected. This in vitro cytotoxic effect correlated to the surface exposure level of PS on the tumor cells. Using xenografts, animals treated with SapC-DOPS showed clear survival benefits and their tumors shrank or disappeared. Furthermore, using a double-tracking method in live mice, we showed that the nanovesicles were specifically targeted to orthotopically-implanted, bioluminescent pancreatic tumors. These data suggest that the acidic phospholipid PS is a biomarker for pancreatic cancer that can be effectively targeted for therapy utilizing cancer-selective SapC-DOPS nanovesicles. This study provides convincing evidence in support of developing a new therapeutic approach to pancreatic cancer.
Related Links	http://dx.doi.org/10.1371/journal.pone.0075507
Starting Page	75507
File Format	PDF
ISSN	19326203
e-ISSN	19326203
Journal	PLoS ONE
Issue Number	10
Volume Number	8
Language	English
Publisher	Public Library of Science
Publisher Date	2013-10-01
Access Restriction	Open
Rights Holder	Public Library of Science
Subject Keyword	Biochemistry, Genetics and Molecular Biology(all) Agricultural and Biological Sciences(all) Medicine(all) Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Correction: Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer

Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles

Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles

Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors

Detection of cancer cells using SapC-DOPS nanovesicles

Detection of cancer cells using SapC-DOPS nanovesicles

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas

NT-06PHOSPHATIDYLSERINE-SELECTIVE TARGETING AND ANTICANCER EFFECTS OF SapC-DOPS NANOVESICLES ON BRAIN TUMORS

Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer

Similar Documents

Correction: Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer

Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles

Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles

Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors

Detection of cancer cells using SapC-DOPS nanovesicles

Detection of cancer cells using SapC-DOPS nanovesicles

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas

NT-06PHOSPHATIDYLSERINE-SELECTIVE TARGETING AND ANTICANCER EFFECTS OF SapC-DOPS NANOVESICLES ON BRAIN TUMORS

Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer